Ketamine use for super-refractory status epilepticus in children
[...]ketamine is also well known for its abuse potential; it is especially popular in Asia, and is known as a post-clubbing drug.1 Use of ketamine for controlling seizures was first reported in the 1990s.2 Ketamine is now an emerging treatment option for status epilepticus (SE), particularly refract...
Gespeichert in:
| Veröffentlicht in: | Hong Kong medical journal = Xianggang yi xue za zhi 2020-12, Vol.26 (6), p.549 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 6 |
| container_start_page | 549 |
| container_title | Hong Kong medical journal = Xianggang yi xue za zhi |
| container_volume | 26 |
| creator | Eva LW Fung Yam, K M Maggie LY Yau |
| description | [...]ketamine is also well known for its abuse potential; it is especially popular in Asia, and is known as a post-clubbing drug.1 Use of ketamine for controlling seizures was first reported in the 1990s.2 Ketamine is now an emerging treatment option for status epilepticus (SE), particularly refractory SE (RSE), defined as ongoing seizures that have not responded one benzodiazepine and another antiepileptic drug, or super-refractory SE (SRSE), defined as SE that continues or recurs [greater than or equal to]24 hours after the onset of anaesthesia, including those cases in which SE recurs on the reduction or withdrawal of anaesthesia.3 Midazolam, thiopentone/pentobarbital and/or propofol are commonly used anaesthetics in these conditions.4 A recent review of ketamine use in RSE in 244 patients (adults and children) suggested an overall efficacy up to 73% to 74%. Recent studies have suggested that with prolonged seizures, the number of activated γ-aminobutyric acid type A (GABAA) receptors on the postsynaptic m |
| doi_str_mv | 10.12809/hkmj208488 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2581855747</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2581855747</sourcerecordid><originalsourceid>FETCH-proquest_journals_25818557473</originalsourceid><addsrcrecordid>eNqNir0KwjAYAIMoWLSTLxBwriafTZNugiiCq3up9StNbdOan8G3t4MP4HQHd4RsONtxUCzfN6--BaZSpWYkAoAsUZLJOYk4gzQBydSSxM7pB2OZkJDLLCLHG_qy1wZpcEjrwVIXRrSJxdqWlR_shzpf-uAojrrD0etqcm1o1ejuadGsyaIuO4fxjyuyvZzvp2sy2uEd0PmiHYI1UypAKK6EkKk8_Hd9AffIQKw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2581855747</pqid></control><display><type>article</type><title>Ketamine use for super-refractory status epilepticus in children</title><source>Directory of Open Access Journals</source><source>EZB Electronic Journals Library</source><creator>Eva LW Fung ; Yam, K M ; Maggie LY Yau</creator><creatorcontrib>Eva LW Fung ; Yam, K M ; Maggie LY Yau</creatorcontrib><description>[...]ketamine is also well known for its abuse potential; it is especially popular in Asia, and is known as a post-clubbing drug.1 Use of ketamine for controlling seizures was first reported in the 1990s.2 Ketamine is now an emerging treatment option for status epilepticus (SE), particularly refractory SE (RSE), defined as ongoing seizures that have not responded one benzodiazepine and another antiepileptic drug, or super-refractory SE (SRSE), defined as SE that continues or recurs [greater than or equal to]24 hours after the onset of anaesthesia, including those cases in which SE recurs on the reduction or withdrawal of anaesthesia.3 Midazolam, thiopentone/pentobarbital and/or propofol are commonly used anaesthetics in these conditions.4 A recent review of ketamine use in RSE in 244 patients (adults and children) suggested an overall efficacy up to 73% to 74%. Recent studies have suggested that with prolonged seizures, the number of activated γ-aminobutyric acid type A (GABAA) receptors on the postsynaptic m</description><identifier>ISSN: 1024-2708</identifier><identifier>EISSN: 2226-8707</identifier><identifier>DOI: 10.12809/hkmj208488</identifier><language>chi ; eng</language><publisher>Hong Kong: Hong Kong Academy of Medicine</publisher><subject>Algorithms ; Anesthesia ; Anticonvulsants ; Cardiovascular disease ; Convulsions & seizures ; Drug dosages ; Hypertension ; Intensive care ; Intracranial pressure</subject><ispartof>Hong Kong medical journal = Xianggang yi xue za zhi, 2020-12, Vol.26 (6), p.549</ispartof><rights>2020. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27903,27904</link.rule.ids></links><search><creatorcontrib>Eva LW Fung</creatorcontrib><creatorcontrib>Yam, K M</creatorcontrib><creatorcontrib>Maggie LY Yau</creatorcontrib><title>Ketamine use for super-refractory status epilepticus in children</title><title>Hong Kong medical journal = Xianggang yi xue za zhi</title><description>[...]ketamine is also well known for its abuse potential; it is especially popular in Asia, and is known as a post-clubbing drug.1 Use of ketamine for controlling seizures was first reported in the 1990s.2 Ketamine is now an emerging treatment option for status epilepticus (SE), particularly refractory SE (RSE), defined as ongoing seizures that have not responded one benzodiazepine and another antiepileptic drug, or super-refractory SE (SRSE), defined as SE that continues or recurs [greater than or equal to]24 hours after the onset of anaesthesia, including those cases in which SE recurs on the reduction or withdrawal of anaesthesia.3 Midazolam, thiopentone/pentobarbital and/or propofol are commonly used anaesthetics in these conditions.4 A recent review of ketamine use in RSE in 244 patients (adults and children) suggested an overall efficacy up to 73% to 74%. Recent studies have suggested that with prolonged seizures, the number of activated γ-aminobutyric acid type A (GABAA) receptors on the postsynaptic m</description><subject>Algorithms</subject><subject>Anesthesia</subject><subject>Anticonvulsants</subject><subject>Cardiovascular disease</subject><subject>Convulsions & seizures</subject><subject>Drug dosages</subject><subject>Hypertension</subject><subject>Intensive care</subject><subject>Intracranial pressure</subject><issn>1024-2708</issn><issn>2226-8707</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqNir0KwjAYAIMoWLSTLxBwriafTZNugiiCq3up9StNbdOan8G3t4MP4HQHd4RsONtxUCzfN6--BaZSpWYkAoAsUZLJOYk4gzQBydSSxM7pB2OZkJDLLCLHG_qy1wZpcEjrwVIXRrSJxdqWlR_shzpf-uAojrrD0etqcm1o1ejuadGsyaIuO4fxjyuyvZzvp2sy2uEd0PmiHYI1UypAKK6EkKk8_Hd9AffIQKw</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Eva LW Fung</creator><creator>Yam, K M</creator><creator>Maggie LY Yau</creator><general>Hong Kong Academy of Medicine</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BVBZV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20201201</creationdate><title>Ketamine use for super-refractory status epilepticus in children</title><author>Eva LW Fung ; Yam, K M ; Maggie LY Yau</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_25818557473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>Algorithms</topic><topic>Anesthesia</topic><topic>Anticonvulsants</topic><topic>Cardiovascular disease</topic><topic>Convulsions & seizures</topic><topic>Drug dosages</topic><topic>Hypertension</topic><topic>Intensive care</topic><topic>Intracranial pressure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Eva LW Fung</creatorcontrib><creatorcontrib>Yam, K M</creatorcontrib><creatorcontrib>Maggie LY Yau</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Complete (ProQuest Database)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>East & South Asia Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Hong Kong medical journal = Xianggang yi xue za zhi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eva LW Fung</au><au>Yam, K M</au><au>Maggie LY Yau</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ketamine use for super-refractory status epilepticus in children</atitle><jtitle>Hong Kong medical journal = Xianggang yi xue za zhi</jtitle><date>2020-12-01</date><risdate>2020</risdate><volume>26</volume><issue>6</issue><spage>549</spage><pages>549-</pages><issn>1024-2708</issn><eissn>2226-8707</eissn><abstract>[...]ketamine is also well known for its abuse potential; it is especially popular in Asia, and is known as a post-clubbing drug.1 Use of ketamine for controlling seizures was first reported in the 1990s.2 Ketamine is now an emerging treatment option for status epilepticus (SE), particularly refractory SE (RSE), defined as ongoing seizures that have not responded one benzodiazepine and another antiepileptic drug, or super-refractory SE (SRSE), defined as SE that continues or recurs [greater than or equal to]24 hours after the onset of anaesthesia, including those cases in which SE recurs on the reduction or withdrawal of anaesthesia.3 Midazolam, thiopentone/pentobarbital and/or propofol are commonly used anaesthetics in these conditions.4 A recent review of ketamine use in RSE in 244 patients (adults and children) suggested an overall efficacy up to 73% to 74%. Recent studies have suggested that with prolonged seizures, the number of activated γ-aminobutyric acid type A (GABAA) receptors on the postsynaptic m</abstract><cop>Hong Kong</cop><pub>Hong Kong Academy of Medicine</pub><doi>10.12809/hkmj208488</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1024-2708 |
| ispartof | Hong Kong medical journal = Xianggang yi xue za zhi, 2020-12, Vol.26 (6), p.549 |
| issn | 1024-2708 2226-8707 |
| language | chi ; eng |
| recordid | cdi_proquest_journals_2581855747 |
| source | Directory of Open Access Journals; EZB Electronic Journals Library |
| subjects | Algorithms Anesthesia Anticonvulsants Cardiovascular disease Convulsions & seizures Drug dosages Hypertension Intensive care Intracranial pressure |
| title | Ketamine use for super-refractory status epilepticus in children |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T16%3A25%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ketamine%20use%20for%20super-refractory%20status%20epilepticus%20in%20children&rft.jtitle=Hong%20Kong%20medical%20journal%20=%20Xianggang%20yi%20xue%20za%20zhi&rft.au=Eva%20LW%20Fung&rft.date=2020-12-01&rft.volume=26&rft.issue=6&rft.spage=549&rft.pages=549-&rft.issn=1024-2708&rft.eissn=2226-8707&rft_id=info:doi/10.12809/hkmj208488&rft_dat=%3Cproquest%3E2581855747%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2581855747&rft_id=info:pmid/&rfr_iscdi=true |